TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

DEVICE3 trials

Sponsors

Abbott Medical Devices

Conditions

Coronary Artery DiseaseCoronary DiseaseCoronary Restenosis

Phase 2

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

CompletedNCT00140101

Abbott Medical DevicesCoronary Artery Disease, Coronary Disease, Coronary Restenosis

Start: 2005-05-31End: 2012-01-31Updated: 2012-01-10

Phase 3

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

CompletedNCT00180310

Abbott Medical DevicesCoronary Artery Disease, Coronary Disease, Coronary Restenosis

Start: 2005-07-31End: 2011-02-28Updated: 2011-07-20

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

CompletedNCT00307047

Abbott Medical DevicesCoronary Artery Disease

Start: 2006-08-31End: 2012-05-31Updated: 2012-11-07

Related Papers

Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents

Circulation Cardiovascular Interventions2015-05-0178 citations

1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.

2014-04-1633 citations

Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.

2012-03-2025 citations

Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.

2011-11-01105 citations

Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.

2011-10-0163 citations

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

2010-12-0169 citations

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

2010-05-01608 citations